Author

Michael Meyer

Observed name: M.P. Meyer

Institution: Vitalant

Observed institution: Vitalant

OpenAlex ID: A5070334197

Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial

2023 · Margaret V Ragni, Scott D Rothenberger, et al. · The Lancet Haematology · 40

Multicenter, Randomized Crossover Trial Comparing Recombinant Von Willebrand Factor and Tranexamic Acid for Heavy Menstrual Bleeding in Von Willebrand Disease

2022 · Margaret V. Ragni, Scott Rothenberger, et al. · Blood

SARS-CoV-2 Viremia Is Associated with Lower Respiratory Tract Viral Load and Plasma Markers of Epithelial Injury and Thrombin Generation in Critically Ill Patients

2022 · M.J. Bittner, J.L. Jacobs, et al.

Works count: 3

Citation count: 40

H-index: 1

I10-index: 1